Misfit of implant prostheses and its impact on clinical outcomes. Definition, assessment and a systematic review of the literature.

BACKGROUND AND AIM Compromised fit between the contact surfaces of screw-retained implant-supported fixed dentures (IFDs) is thought to create uncontrolled strains in the prosthetic components and peri-implant tissues, thus evoking biological and technical complications such as bone loss, screw loosening, component fractures and, at worst, loss of implants or prostheses. The aim of this systematic review was to evaluate the impact of marginal misfit on the clinical outcomes of IFDs, and to elucidate definition and assessment methods for passive fit. MATERIALS AND METHODS A systematic review of the literature was conducted with a PICO question: "For partially or complete edentulous subjects with screw-retained IFDs, does the marginal misfit at the implant-prosthesis interfaces have an impact on the clinical outcomes?". A literature search was performed electronically in PubMed (MEDLINE) with the help of Boolean operators to combine key words, and by hand search in relevant journals. English written in vivo studies published before August 31, 2016 that reported on both clinical outcome and related implant prosthesis misfit (gap, strains, torque) were selected using predetermined inclusion criteria. RESULTS The initial search yielded 2626 records. After screening and a subsequent filtering process, five human and five animal studies were included in the descriptive analysis. The selected studies used different methods to assess misfit (linear distortion, vertical gap, strains, screw torque). While two human studies evaluated the biological response and technical complications prospectively over 6 and 12 months, the animal studies had an observation period < 12 weeks. Four human studies analysed retrospectively the 3 to 32 years' outcomes. Screw-related complications were observed, but biological sequelae could not be confirmed. Although the animal studies had different designs, bone adaptation and implant displacement was found in histological analyses. Due to the small number of studies and the heterogenic designs and misfit assessment methods, no meta-analysis of the data could be performed. CONCLUSIONS The current literature provides insufficient evidence as to the effect of misfit at the prosthesis-implant interface on clinical outcomes of screw-retained implant-supported fixed dentures. Marginal gaps and static strains due to screw tightening were not found to have negative effects on initial osseointegration or peri-implant bone stability over time. Based on two clinical studies, the risk for technical screw-related complications was slightly higher. While the degree of tolerable misfit remains a matter of debate, the present data do not imply that clinicians neglect good fit, but aim to achieve the least misfit possible. Conflict of interest statement: The authors declare no conflict of interest. The review was conducted as part of the 2016 Foundation of Oral Rehabilitation Consensus Conference on "Prosthetic Protocols in Implant-based Oral Rehabilitation"

Resistencia de dientes restaurados con postes prefabricados ante cargas de máxima intercuspidación, masticación y bruxismo Resistance of teeth restored with prefabricated posts to maximum intercuspidation loads, mastication and bruxism

Objetivo: determinar por el método de los elementos finitos la resistencia de dientes restaurados con postes prefabricados ante cargas estáticas de máxima intercuspidación y cargas cíclicas de masticación y bruxismo y analizar el efecto de la pérdida periodontal en la resistencia de las restauraciones. Métodos: se realizó una investigación in vitro mediante el método de los elementos finitos de dientes con pérdida periodontal, rehabilitados con postes prefabricados en fibra de vidrio, carbono y titanio. Los dientes fueron reconstruidos a partir de imágenes tomográficas de un paciente periodontalmente sano. Resultados: se muestra que ante cargas estáticas las rehabilitaciones no presentan tendencia a la falla, independientemente del material del poste o del grado de pérdida periodontal. En el caso de bruxismo y pérdida periodontal de 4 mm, la dentina presenta una durabilidad de 60 000 ciclos independiente del material del poste. Para cargas de masticación y periodonto sano, la falla en la dentina ocurre a los 100 000 ciclos con poste en titanio, 200 000 ciclos con poste en fibra de carbono y 1 100 000 ciclos con poste en fibra de vidrio. Para una pérdida periodontal de 2 mm la durabilidad de la dentina se reduce a 4 000 ciclos con poste en titanio, 5 000 ciclos con poste en fibra de carbono y 7 000 ciclos con poste en fibra de vidrio. Para pérdida periodontal de 4 mm, la durabilidad de la dentina se estima en 1 000 ciclos, independientemente del material del poste utilizado. Conclusiones: ante carga estática de máxima intercuspidación las rehabilitaciones con postes prefabricados en fibra de vidrio, carbono y titanio no presentan tendencia a la falla, independientemente del grado de pérdida periodontal. Ante cargas cíclicas, los postes prefabricados presentan una vida útil infinita, y es la dentina la estructura más afectada ante dichos eventos.Objective: using the finite element method, determine the resistance of teeth restored with prefabricated posts to maximum static intercuspidation loads, cyclical mastication loads and bruxism, and analyze the effect of periodontal loss on resistance by restorations. Methods: using the finite element method, an in vitro study was conducted of teeth with periodontal loss rehabilitated with prefabricated glass fiber, carbon and titanium posts. Reconstruction of the teeth was based on tomographic images from a periodontically healthy patient. Results: it was shown that rehabilitations did not tend to yield to static loads, irrespective of post material or the degree of periodontal loss. For bruxism and 4 mm periodontal loss, dentin durability was 60 000 cycles, irrespective of post material. For mastication loads and a healthy periodont, dentin failure occurs at 100 000 cycles with titanium posts, 200 000 cycles with carbon fiber posts, and 1 100 000 cycles with glass fiber posts. For 2 mm periodontal loss, dentin durability decreased to 4 000 cycles with titanium posts, 5 000 cycles with carbon fiber posts, and 7 000 cycles with glass fiber posts. For 4 mm periodontal loss, dentin durability is estimated at 1 000 cycles, irrespective of post material. Conclusions: restorations with glass fiber, carbon and titanium prefabricated posts do not yield to maximum static intercuspidation loads, irrespective of the degree of periodontal loss. Prefabricated posts exhibit endless resistance to cyclic loads. Dentin is the structure most severely affected by such events

Resistencia de dientes restaurados con postes prefabricados ante cargas de máxima intercuspidación, masticación y bruxismo

Objetivo: determinar por el método de los elementos finitos la resistencia de dientes restaurados con postes prefabricados ante cargas estáticas de máxima intercuspidación y cargas cíclicas de masticación y bruxismo y analizar el efecto de la pérdida periodontal en la resistencia de las restauraciones. Métodos: se realizó una investigación in vitro mediante el método de los elementos finitos de dientes con pérdida periodontal, rehabilitados con postes prefabricados en fibra de vidrio, carbono y titanio. Los dientes fueron reconstruidos a partir de imágenes tomográficas de un paciente periodontalmente sano. Resultados: se muestra que ante cargas estáticas las rehabilitaciones no presentan tendencia a la falla, independientemente del material del poste o del grado de pérdida periodontal. En el caso de bruxismo y pérdida periodontal de 4 mm, la dentina presenta una durabilidad de 60 000 ciclos independiente del material del poste. Para cargas de masticación y periodonto sano, la falla en la dentina ocurre a los 100 000 ciclos con poste en titanio, 200 000 ciclos con poste en fibra de carbono y 1 100 000 ciclos con poste en fibra de vidrio. Para una pérdida periodontal de 2 mm la durabilidad de la dentina se reduce a 4 000 ciclos con poste en titanio, 5 000 ciclos con poste en fibra de carbono y 7 000 ciclos con poste en fibra de vidrio. Para pérdida periodontal de 4 mm, la durabilidad de la dentina se estima en 1 000 ciclos, independientemente del material del poste utilizado. Conclusiones: ante carga estática de máxima intercuspidación las rehabilitaciones con postes prefabricados en fibra de vidrio, carbono y titanio no presentan tendencia a la falla, independientemente del grado de pérdida periodontal. Ante cargas cíclicas, los postes prefabricados presentan una vida útil infinita, y es la dentina la estructura más afectada ante dichos eventos

Tactile misfit detection ability at the implant-abutment interface of internal connection dental implants: an in-vitro study.

OBJECTIVE The aim of this in-vitro study was to investigate the tactile assessment ability at the implant impression-taking stage. METHODS Thirty clinicians (18 novices, 12 experts) were included for a tactile fit assessment by using a used/new probe (tip diameter 100 µm/20 µm). Six implant replicas and related impression copings of two internal connection implant systems were used, each with a perfect fit (0 µm) and defined vertical micro gaps of 8, 24, 55, 110 and 220 µm at the interface. Statistical analysis was performed using descriptive methods and non-parametric tests with a focus on specificity (ability to detect perfect fit), sensitivity (ability to detect misfit), and predictive values. P-values <5% were considered statistically significant. RESULTS The tactile assessment showed a mean total sensitivity for the Straumann and Nobel Biocare systems of 83% and 80% with a used probe, and 91% and 92% with a new probe, respectively. The mean total specificities were 33% and 20% with a used probe and 17% and 3% with a new probe, respectively. No statistical significance was observed between novice and expert clinicians concerning their tactile assessment ability. CONCLUSIONS The ability to detect a perfect fit (specificity) with a probe was very poor for both implant systems and impaired with the use of a new probe. The use of a new probe improved the gap detection ability (sensitivity) significantly at the expense of the specificity. A combination of additional chairside techniques with training and calibration could improve clinicians' ability to correctly assess the fit/misfit at the implant-abutment interface

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Abstract Background Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, https://doi.org/10.17605/OSF.IO/GEHFX ). Methods In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung–Knapp–Sidik–Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. Results A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. Conclusions Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

Abstract Background Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, https://doi.org/10.17605/OSF.IO/GEHFX ). Methods In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung–Knapp–Sidik–Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. Results A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. Conclusions Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care